SEC Form 4 · accession 0001127602-18-015501
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Jonas
Officer — EVP Legal Affairs,Gen. Counsel
Period of report
Apr 27, 2018
Accepted (ET)
Apr 30, 2018 · 2:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2018 | M | 4,680 | $44.90 | A | 23,245 | D | |
| Common Stock | Apr 27, 2018 | F | 3,717 | $65.25 | D | 19,528 | D | |
| Common StockF1 | Apr 27, 2018 | S | 2,000 | $65.58 | D | 17,528 | D | |
| Common Stock | Apr 27, 2018 | G | 100 | $0.00 | D | 17,428 | D | |
| Common Stock | Apr 27, 2018 | G | 100 | $0.00 | A | 100 | I | Daughter |
| Common Stock | Apr 27, 2018 | G | 100 | $0.00 | D | 17,328 | D | |
| Common Stock | Apr 27, 2018 | G | 100 | $0.00 | A | 100 | I | Daughter |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F4 | $44.90 | Apr 27, 2018 | M | 4,680 | D | — | Jun 1, 2024 | Common Stock | 4,680 | 3,120 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.575 to $65.589. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- F2This transaction is a gift of securities by the reporting person to his daughter, who shares the reporting person's household.
- F3This transaction is a gift of securities by the reporting person to his daughter, who shares the reporting person's household.
- F4The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.